PUSINTIN Trademark

Trademark Overview


On Thursday, April 23, 2020, a trademark application was filed for PUSINTIN with the United States Patent and Trademark Office. The USPTO has given the PUSINTIN trademark a serial number of 88884223. The federal status of this trademark filing is REGISTERED as of Tuesday, November 17, 2020. This trademark is owned by TOT BIOPHARM COMPANY LIMITED. The PUSINTIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in chemotherapy; Tumor suppressing agents; Anti-cancer preparations; Anti-sarcoma preparations; Pharmaceutical products for the treatment of cancer; Capsules sold empty for pharmaceuticals; Pharmaceutical preparations for the treatment of cancer; chemical preparations for medical purposes, namely, drugs for the treatment of cancer; Chemical preparations for pharmaceutical purposes, namely, chemical preparations for the treatment of cancer; Medicinal preparations for human use for the treatment of cancer; Injectable pharmaceuticals, namely, injectable pharmaceuticals for the treatment of cancer; Biochemical preparations for medical use, namely, biochemical preparations for the treatment of cancer; Gelatin capsules sold empty for pharmaceuticals
pusintin

General Information


Serial Number88884223
Word MarkPUSINTIN
Filing DateThursday, April 23, 2020
Status700 - REGISTERED
Status DateTuesday, November 17, 2020
Registration Number6199280
Registration DateTuesday, November 17, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 1, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for use in chemotherapy; Tumor suppressing agents; Anti-cancer preparations; Anti-sarcoma preparations; Pharmaceutical products for the treatment of cancer; Capsules sold empty for pharmaceuticals; Pharmaceutical preparations for the treatment of cancer; chemical preparations for medical purposes, namely, drugs for the treatment of cancer; Chemical preparations for pharmaceutical purposes, namely, chemical preparations for the treatment of cancer; Medicinal preparations for human use for the treatment of cancer; Injectable pharmaceuticals, namely, injectable pharmaceuticals for the treatment of cancer; Biochemical preparations for medical use, namely, biochemical preparations for the treatment of cancer; Gelatin capsules sold empty for pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 4, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTOT BIOPHARM COMPANY LIMITED
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSuzhou, Jiangsu 215028
CN

Party NameTOT BIOPHARM COMPANY LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSuzhou, Jiangsu 215028
CN

Party NameTOT BIOPHARM COMPANY LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSuzhou, Jiangsu 215028
CN

Trademark Events


Event DateEvent Description
Tuesday, November 17, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, September 1, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 1, 2020PUBLISHED FOR OPPOSITION
Wednesday, August 12, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 28, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 24, 2020EXAMINER'S AMENDMENT ENTERED
Friday, July 24, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 24, 2020EXAMINERS AMENDMENT E-MAILED
Friday, July 24, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, July 16, 2020ASSIGNED TO EXAMINER
Monday, May 4, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 27, 2020NEW APPLICATION ENTERED IN TRAM